Acarbose
Alpha-glucosidase inhibitor that blunts glucose excursions.
Notify me when meaningful evidence changes.
0
Insufficient evidence · Stable
No history yet
⚠ Prescription or off-label use
Approved for diabetes. Use for longevity is off-label.
Current assessment
One of the more reliable lifespan extenders in the Interventions Testing Program, with a notably larger effect in male mice.
- Regulatory status
- Approved other indication
- Availability
- Prescription only
- Category
- Experimental off label
- Human studies tracked
- 0
Evidence breakdown
Human evidence
0
Animal evidence
0
Mechanistic
0
Safety
50
What changed
Evidence events affecting this intervention
No published evidence events yet
Evidence timeline
Every recorded score change
No score history yet
Major human studies
No human studies tracked yet
Animal and mechanistic evidence
No preclinical studies tracked yet